Federal contract award

75F40122C00206

THERE IS AN INCREASED NEED FOR STRATEGIC AND TACTICAL PLANNING AND ANALYSIS, CONTINUOUS PROCESS IMPROVEMENT, ACQUISITION ASSISTANCE, AND CONCEPTUAL PLANNING ACROSS FDA. THE COVID-19 PANDEMIC HIGHLIGHTED THE NEED FOR FEDERAL HEALTH AGENCIES TO HAVE DY

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS541611 — Administrative Management and General Management Consulting Services
PSCR406 — Policy Review/Development Services
Parent award / vehicleNot reported
Set-aside8(A) SOLE SOURCE
Pricing typeLABOR HOURS
Obligations$3.8M
Current contract value$3.8M
Potential contract value / ceiling$3.8M
Start dateSep 30, 2022
Current end dateSep 29, 2025
Potential end dateSep 29, 2025
Latest award activityJun 3, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 3, 2026P00005$-550.8KTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.
Mar 27, 2025P00004$0EOI::ENDING RADICAL AND WASTEFUL GOVERNMENT DEI PROGRAMS AND PREFERENCING (JANUARY 20, 2025)::EOI NOTICE OF TERMINATION FOR CONVENIENCE
Jul 10, 2024P00003$1.4MAWARD FOR OEM SUPPORT SERVICES
Jun 13, 2024P00002$510.0KTHERE IS AN INCREASED NEED FOR STRATEGIC AND TACTICAL PLANNING AND ANALYSIS, CONTINUOUS PROCESS IMPROVEMENT, ACQUISITION ASSISTANCE, AND CONCEPTUAL PLANNING ACROSS FDA. THE COVID-19 PANDEMIC HIGHLIGHTED THE NEED FOR FEDERAL HEALTH AGENCIES TO HAVE DY
Sep 13, 2023P00001$1000.0KTHERE IS AN INCREASED NEED FOR STRATEGIC AND TACTICAL PLANNING AND ANALYSIS, CONTINUOUS PROCESS IMPROVEMENT, ACQUISITION ASSISTANCE, AND CONCEPTUAL PLANNING ACROSS FDA. THE COVID-19 PANDEMIC HIGHLIGHTED THE NEED FOR FEDERAL HEALTH AGENCIES TO HAVE DY
Sep 30, 20220$1.5MTHERE IS AN INCREASED NEED FOR STRATEGIC AND TACTICAL PLANNING AND ANALYSIS, CONTINUOUS PROCESS IMPROVEMENT, ACQUISITION ASSISTANCE, AND CONCEPTUAL PLANNING ACROSS FDA. THE COVID-19 PANDEMIC HIGHLIGHTED THE NEED FOR FEDERAL HEALTH AGENCIES TO HAVE DY

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.